SalvadorBeatriz Cardiff UniversityUnited Kingdom

I finished my BSc in Biology at Universidad de Alcalá (Alcalá de Henares, Spain) in 2013, and then moved to San Pablo CEU University (Madrid, Spain) to study my MSc in Clinic Research in Oncology (2013-2014). In 2014 I started my PhD at the Spanish National Cancer Research Institute (CNIO) supervised by Dr. Manuel Hidalgo and Dr. Marcos Malumbres, too study CDK4/6 inhibitors in combination with standard chemotherapies for the treatment of pancreatic cancer. After finishing my PhD, I did a short 5-month postdoc at Malumbres lab. In 2019 I moved to Cardiff University to Hogan lab to study how mutant cells avoid tissue homeostasis mechanisms and remain in the pancreas to initiate pancreatic cancer. In 2022 I was awarded a Pancreatic Cancer UK Foundation Fellowship to study the Cancer Initiating Cells in pancreatic cancer. In June 2026 I joined Barts Cancer Institute in London as Group Leader supported by a CRUK Career Development Fellowship to continue investigating pancreatic cancer initiation.